Dermatology Devices Market Analysis

Dermatology Devices Market Analysis

Under product, the dermatology devices market share from the treatment devices segment is anticipated to exhibit significant growth at over 10.5% CAGR from 2023 to 2032. Massive investments by industry leaders for expediating R&D operations for continuous development of laser technologies that provide rapid, secure, and reliable procedures, which is expected to propel business expansion through 2032. Additionally, rising demand for laser tattoo removal is estimated to drive laser dermatology devices, thereby impelling segment development. Diagnostic devices segment is projected to register over 9.6% CAGR between 2023 and 2032 propelled by increasing expenditure on skin care in developing countries.
 

The report cites that the dermatology devices market share from the psoriasis application segment is anticipated to grow at more than 10% CAGR through 2032 due to the growing prevalence of psoriasis in the world. According to reports, psoriasis affects roughly 25 million individuals globally, thereby fueling the demand for dermatology devices for treatment. Additionally, ongoing technological developments in psoriasis treatment, as well as a growing preference for teledermatology and eHealth digital technologies for convenient access to psoriasis treatments, are expected to support segment expansion.
 

In terms of end-use, the dermatology centers segment held more than 37% share of the dermatology devices market in 2022 and is anticipated to attain significant growth through the forecast timeframe. The rising number of people suffering from dermatological problems, such as acne, psoriasis, and eczema, is driving segment statistics. Furthermore, favorable government initiatives encouraging the development of dermatological clinics and sophisticated healthcare infrastructure are likely to stimulate segment development.
 

Europe dermatology devices market is expected to reach over USD 7.5 billion by 2032 on account of the rising prevalence of skin cancer. According to a survey from 2022 by the European Academy of Dermatology and Venereology (EADV), 1.71% of adult Europeans have skin cancer. The rising demand for facial surgeries to improve facial aesthetics among European women is likely to support market progression. Furthermore, massive investments in digital dermatology are catching up with the rest of the digital health industries, which is foreseen to propel regional revenue.